Insider Transactions in Q1 2025 at Koru Medical Systems, Inc. (KRMD)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2025
|
Joseph M. Manko Jr. Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,870
+0.1%
|
-
|
|
Mar 19
2025
|
Linda M Tharby Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
29,813
-2.77%
|
$59,626
$2.83 P/Share
|
|
Mar 19
2025
|
Christopher Pazdan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,849
-15.21%
|
$25,698
$2.83 P/Share
|
|
Mar 19
2025
|
Christopher Pazdan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
36,331
+30.07%
|
-
|
|
Mar 17
2025
|
Linda M Tharby Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,848
-0.82%
|
$17,696
$2.89 P/Share
|
|
Mar 17
2025
|
Linda M Tharby Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,968
+1.45%
|
-
|
|
Mar 17
2025
|
Thomas Edward Adams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,988
-36.79%
|
$3,976
$2.89 P/Share
|
|
Mar 17
2025
|
Thomas Edward Adams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,404
+50.0%
|
-
|
|
Mar 17
2025
|
Kenneth E Miller Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,168
-36.79%
|
$4,336
$2.89 P/Share
|
|
Mar 17
2025
|
Kenneth E Miller Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,893
+50.0%
|
-
|
|
Mar 17
2025
|
Christopher Pazdan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,641
-3.3%
|
$3,282
$2.89 P/Share
|
|
Mar 17
2025
|
Christopher Pazdan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,063
+9.23%
|
-
|
|
Feb 06
2025
|
Joseph M. Manko Jr. Director |
SELL
Other acquisition or disposition
|
Indirect |
16,187
-0.27%
|
-
|
|
Jan 21
2025
|
Joseph M. Manko Jr. Director |
BUY
Other acquisition or disposition
|
Direct |
351,948
+40.49%
|
-
|
|
Jan 21
2025
|
Joseph M. Manko Jr. Director |
SELL
Other acquisition or disposition
|
Indirect |
2,000,000
-57.26%
|
-
|
|
Jan 21
2025
|
Joseph M. Manko Jr. Director |
BUY
Other acquisition or disposition
|
Indirect |
1,000,000
+50.0%
|
-
|
|
Jan 03
2025
|
R John Fletcher Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,905
+2.91%
|
$17,715
$3.81 P/Share
|
|
Jan 03
2025
|
Donna French Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+4.99%
|
$11,811
$3.81 P/Share
|
|
Jan 03
2025
|
Robert Cascella Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+5.02%
|
$11,811
$3.81 P/Share
|
|
Jan 03
2025
|
Edward Wholihan Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+12.44%
|
$11,811
$3.81 P/Share
|
|
Jan 03
2025
|
Shahriar Matin Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,937
+4.83%
|
$11,811
$3.81 P/Share
|